Pmv Pharmaceuticals Inc Share Price

NASDAQ: PMVP

Small Cap

$1.25

+0.05

(+4.58%)

as on September 18, 2025 at 1:29 am IST

$₹

Pmv Pharmaceuticals Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$1.21
Day's Price Range
$1.35
$1.25
3.20%
Downside
8.00%
Upside
52 Week's Low
52 Week's High
$0.81
52-Week Price Range
$1.84
$1.25
35.20%
Downside
47.20%
Upside

Pmv Pharmaceuticals Inc share price movements today

Previous Close: $1.20
Open: $1.21
Volume: 1.7M
Day's Low - High: $1.21 - $1.35
52 Week Low - High: $0.81 - $1.84

Pmv Pharmaceuticals Inc Historical Returns

1 Month Return: -21.05 %
3 Month Return: + 10.09 %
1 Year Return: -20 %
3 Year Return: -90.47 %
5 Year Return: 0 %

Pmv Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Pmv Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$63.6M

EPS (TTM)

-1.5675

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-90.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

14636700.00%

Pmv Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pmv Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Pmv Pharmaceuticals Inc	BUY	$63.6M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Pmv Pharmaceuticals Inc Stock including INR - Dollar returns

The Pmv Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Pmv Pharmaceuticals Inc investment value today

Current value as on today

₹87,932

Returns

₹12,068

(-12.07%)

Returns from Pmv Pharmaceuticals Inc Stock

₹16,667 (-16.67%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Pmv Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Pmv Pharmaceuticals Inc. Average target price of $8.4

Pmv Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Pmv Pharmaceuticals Inc.

What analysts predicted

85.12%UPSIDE

Target Price

$8.4

Current Price

$1.25

Analyzed by

12 Analysts

Target

$8.40

Pmv Pharmaceuticals Inc target price $8.4, a slight upside of 85.12% compared to current price of $1.25. According to 12 analysts rating.

Pmv Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Pmv Pharmaceuticals Inc Stock has increased by 88% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:88% versus previous 30 day period

Pmv Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	1	-	-	-	-	-	-
Gross Profit	0	0	0	1	0	0	-	-	-	0
Operating Income	-21	-20	-19	-18	-18	-20	-21	-25	-21	-22
EBITDA	-21	-19	-19	-18	-17	-19	-21	-25	-21	-21
Interest Expense	2	-	-	2	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-19	-17	-16	-15	-15	-17	-19	-23	-19	-21
Income Tax Expense	-2	0	0	0	0	-16	0	-	-2	0
Net Income	-16	-17	-16	-15	-15	-1	-19	-23	-17	-21
Net Profit Margin	0.00%	0.00%	0.00%	-973.79%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Pmv Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	-1	0	-1	-
Operating Income	-18	-26	-34	-58	-77	-80	-85
EBITDA	-18	-26	-34	-57	-76	-78	-73
Interest Expense	-	1	0	0	4	-	-
Depreciation	0	0	0	0	0	0	1
Income Before Tax	-17	-25	-34	-57	-73	-68	-74
Income Tax Expense	0	0	0	0	0	0	-16
Net Income	-17	-25	-34	-57	-73	-68	-58
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Pmv Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-17	-16	-15	-15	-1	-19	-23	-17	-21
Operating Cash Flow	-12	-15	-12	-16	-1	-16	-16	-18	-18
Investing Cash Flow	-63	-33	-2	26	2	17	7	28	10
Financing Cash Flow	2	33	0	-	0	-	0	0	0
Change in Cash	-74	-16	-14	9	0	0	-8	10	-7

Pmv Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-25	-34	-57	-73	-68	-58
Operating Cash Flow	-22	-32	-46	-63	-55	-51
Investing Cash Flow	3	27	-143	-1	-50	53
Financing Cash Flow	61	292	2	0	35	0
Change in Cash	42	288	-188	-64	-70	2

Global Institutional Holdings in Pmv Pharmaceuticals Inc

Funds	Holdings
Orbimed Advisors, LLC	12.46%
BML Capital Management LLC	7.21%
Sio Capital Management, LLC	7.19%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)	6.37%
Partner Fund Management LP	6.36%

See all

Insights on Pmv Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 207.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 89.4%
NEGATIVE IMPACT
Price Dip
In the last 1 month, PMVP stock has moved down by -22.8%

About Pmv Pharmaceuticals Inc

pmv pharmaceuticals, inc., a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. its lead product candidate is pc14586, a small molecule that corrects and restores p53 function. the company also develops product candidates for p53 r273h hotspot mutation and other p53 hotspot mutations. pmv pharmaceuticals, inc. was formerly known as pj pharmaceuticals, inc. and changed to in july 2013. the company was founded in 2013 and is headquartered in cranbury, new jersey.

Organisation	Pmv Pharmaceuticals Inc
Headquarters	400 Alexander Park Drive, Princeton, NJ, United States, 08540
Industry	Commercial Services
CEO	Dr. David H. Mack Ph.D.
E-voting on shares	Click here to vote

Key Management of Pmv Pharmaceuticals Inc

Name	Title
Dr. Deepika Jalota Pharm.D.	Chief Development Officer
Mr. Robert Ticktin J.D.	General Counsel, COO & Company Secretary
Ms. Crystal Zuckerman	Vice President of Human Resources
Dr. Binh Vu Ph.D.	Senior Vice President of Drug Discovery & CMC
Ms. Laura De Leon	VP & Head of Clinical Operations
Dr. David H. Mack Ph.D.	Co-Founder, CEO, President & Director
Mr. Michael Carulli	Chief Financial Officer
Mr. Tim Smith	Senior VP and Head of Corporate Development & Investor Relations
Dr. Marc Fellous M.D.	Senior VP and Head of Clinical Development & Medical Affairs
Dr. Arnold J. Levine Ph.D.	Co-Founder, Independent Director & Member of Scientific Advisory Board

FAQs

What is Pmv Pharmaceuticals Inc share price today?

Pmv Pharmaceuticals Inc share price today is $1.25 as on September 18, 2025 at 1:29 am IST at the close of the market. Pmv Pharmaceuticals Inc share today touched a day high of $1.35 and a low of $1.21.

What is the 52 week high and 52 week low for Pmv Pharmaceuticals Inc share?

Pmv Pharmaceuticals Inc share touched a 52 week high of $1.84 on September 10, 2025 and a 52 week low of $0.81 on May 16, 2025. Pmv Pharmaceuticals Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $1.25,which is 32.07% down from its 52 week high and 54.32% up from its 52 week low.

What is Pmv Pharmaceuticals Inc's market capitalisation today?

Pmv Pharmaceuticals Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Pmv Pharmaceuticals Inc Stock (PMVP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pmv Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pmv Pharmaceuticals Inc Shares that will get you 1.2000 shares as per Pmv Pharmaceuticals Inc share price of $1.25 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Pmv Pharmaceuticals Inc Stock (PMVP) from India?

Indian investors can start investing in Pmv Pharmaceuticals Inc (PMVP) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 11:46 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Pmv Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 11:46 am IST). Based on Pmv Pharmaceuticals Inc share’s latest price of $1.25 as on September 18, 2025 at 1:29 am IST, you will get 8.0000 shares of Pmv Pharmaceuticals Inc. Learn more about fractional shares .